| Title |
Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an acute cardiovascular event
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2009
|
| DOI | 10.1002/14651858.cd006743.pub2 |
| Pubmed ID | |
| Authors |
Marco I Perez, Vijaya M Musini, James M Wright |
| Abstract |
Acute cardiovascular events represent a therapeutic challenge. Blood pressure lowering drugs are commonly used and recommended in the early phase of these settings. This review analyses randomized controlled trial (RCT) evidence for this approach. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 33% |
| Denmark | 1 | 33% |
| Ecuador | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 196 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| India | 1 | <1% |
| Ireland | 1 | <1% |
| Unknown | 192 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 30 | 15% |
| Researcher | 26 | 13% |
| Student > Bachelor | 23 | 12% |
| Student > Ph. D. Student | 21 | 11% |
| Student > Postgraduate | 15 | 8% |
| Other | 40 | 20% |
| Unknown | 41 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 104 | 53% |
| Nursing and Health Professions | 14 | 7% |
| Psychology | 8 | 4% |
| Social Sciences | 7 | 4% |
| Biochemistry, Genetics and Molecular Biology | 6 | 3% |
| Other | 14 | 7% |
| Unknown | 43 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2022.
All research outputs
#1,598,386
of 25,540,105 outputs
Outputs from Cochrane database of systematic reviews
#3,431
of 13,152 outputs
Outputs of similar age
#4,609
of 107,183 outputs
Outputs of similar age from Cochrane database of systematic reviews
#9
of 85 outputs
Altmetric has tracked 25,540,105 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,152 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,183 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.